I am not sure why this quarterly is becoming such a big issue. For me CardioCel has massive potential but it does take time for it to become main stream. So we don't need validation from the quarterly for the true long term-ers...,
AHZ and HSV, page-16
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
-0.120(0.91%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $13.79 | $13.84 | $13.02 | $314.6K | 23.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1250 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.17 | 201 | 2 |
View Market Depth
| Last trade - 12.46pm 16/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |